2 min read

Israeli Medical Technology: Research, Startups, and Commercialization

Israeli research reaches medical markets through several routes: licensing university inventions, sponsored research with industry, and creating new companies. Yissum, the Hebrew University’s technology-transfer company, describes each of these pathways.

Miriam Bernstein

Miriam Bernstein is the pen name of Hasbara’s Resources desk. Every article is sourced and cited.

Medical products often begin as research findings that need further engineering, testing, regulatory review, and investment before they can reach patients. Israeli universities and research organizations use technology-transfer companies, industry agreements, and startup formation to move some discoveries toward commercial development.

Yissum, founded in 1964, is the Hebrew University of Jerusalem’s technology-transfer company. It works with researchers and commercial partners to license university inventions and know-how, arrange sponsored research, and support spin-off companies. The university’s research office identifies Yissum as its technology-transfer company. This is one documented institutional model, rather than a description of every Israeli university or medical startup.

Licensing and sponsored research

A research institution can license intellectual property to a company that has the capacity to develop and sell a product. Yissum describes licensing agreements for patented or copyrighted inventions and know-how, with terms shaped around the project and partner. A license gives a company rights to develop specified technology; it does not itself establish that a medical product is safe, effective, or approved.

Sponsored research creates a different link. An outside partner funds work with university researchers, often to investigate an early technical question or advance a technology. Results may later support further research, a license, or company formation. Each stage carries its own technical and commercial decisions.

When a startup is the route

A spin-off can be formed when a technology needs a dedicated team and outside capital to develop it. The research organization may help with intellectual property and licensing while founders recruit engineers, clinical experts, and business staff. Medical devices also need testing with intended users and must satisfy the regulatory requirements of the markets where they will be sold.

These routes can overlap: a university license may underpin a startup, while sponsored research helps resolve a development question. The path depends on the invention, the people available to develop it, and the evidence needed for its intended use. For a specific example of an Israeli medical-device company growing through product development and acquisition, see Given Imaging and PillCam. OrCam provides a separate example of a company building assistive reading technology.

Sources

  1. 1.https://www.yissum.co.il/about-us/
  2. 2.https://www.yissum.co.il/partnership-models/
  3. 3.https://en-research.huji.ac.il/sites/default/files/en.mop/files/research_at_hebrew_u.pdf